Drug Type Small molecule drug |
Synonyms MASH, IPF, other(Variant Bio) |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization Variant Bio, Inc.Startup |
Active Organization Variant Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | US | Variant Bio, Inc.Startup | 08 May 2024 |
Metabolic dysfunction-associated steatotic liver disease | Preclinical | US | Variant Bio, Inc.Startup | 08 May 2024 |